Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Rothenberg

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|December 1, 1992
Clinical trials with the topoisomerase I inhibitorsH A Burris, M L Rothenberg, J G Kuhn, et al.
Annals of the New York Academy of Sciences|February 24, 2001
p53 and p21 are major cellular determinants for DNA topoisomerase I-mediated radiation sensitization in mammalian cellsA Y Chen, P B Scruggs, L Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.
International Journal of Oncology|September 15, 1998
Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cellsY Gazitt, M L Rothenberg, S G Hilsenbeck, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology GroupD S Alberts, C Jiang, P Y Liu, et al.
The American Journal of Pathology|July 1, 1995
Tumor angiogenesis in advanced stage ovarian carcinomaH C Hollingsworth, E C Kohn, S M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancerM L Rothenberg, R F Ozols, E Glatstein, et al.
Journal of the National Cancer Institute|November 16, 1988
High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancerM L Rothenberg, Y Ostchega, S M Steinberg, et al.
Cancer|April 3, 1999
An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinomaA M Storniolo, N H Enas, C A Brown, et al.
Investigational New Drugs|January 1, 1997
Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancerJ J Sharma, B Razvillas, C D Stephens, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|December 1, 1992
Clinical trials with the topoisomerase I inhibitorsH A Burris, M L Rothenberg, J G Kuhn, et al.
Annals of the New York Academy of Sciences|February 24, 2001
p53 and p21 are major cellular determinants for DNA topoisomerase I-mediated radiation sensitization in mammalian cellsA Y Chen, P B Scruggs, L Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.
International Journal of Oncology|September 15, 1998
Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cellsY Gazitt, M L Rothenberg, S G Hilsenbeck, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology GroupD S Alberts, C Jiang, P Y Liu, et al.
The American Journal of Pathology|July 1, 1995
Tumor angiogenesis in advanced stage ovarian carcinomaH C Hollingsworth, E C Kohn, S M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancerM L Rothenberg, R F Ozols, E Glatstein, et al.
Journal of the National Cancer Institute|November 16, 1988
High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancerM L Rothenberg, Y Ostchega, S M Steinberg, et al.
Cancer|April 3, 1999
An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinomaA M Storniolo, N H Enas, C A Brown, et al.
Investigational New Drugs|January 1, 1997
Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancerJ J Sharma, B Razvillas, C D Stephens, et al.
Pageof 7